Smokeless tobacco: An emerging addiction

Jon Owen Ebbert, Alan B. Carr, Lowell C. Dale

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Smokeless tobacco use is prevalent in the United States and long-term use leads to significant morbidity. ST users are exposed to high levels of nicotine and are observed to graduate to higher nicotine-containing ST products, perpetuating nicotine dependence. Although few proved pharmacotherapies exist, available evidence suggests that bupropion SR might be effective for increasing ST abstinence rates. Behavioral therapies that include an oral examination may be especially effective for this population of tobacco users. Nicotine replacement therapy should be used to treat withdrawal symptoms in ST users attempting to stop.

Original languageEnglish (US)
Pages (from-to)1593-1605
Number of pages13
JournalMedical Clinics of North America
Volume88
Issue number6
DOIs
StatePublished - Nov 2004

Fingerprint

Smokeless Tobacco
Nicotine
Bupropion
Oral Diagnosis
Tobacco Use Disorder
Substance Withdrawal Syndrome
Tobacco Use
Tobacco
Morbidity
Drug Therapy
Therapeutics
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Smokeless tobacco : An emerging addiction. / Ebbert, Jon Owen; Carr, Alan B.; Dale, Lowell C.

In: Medical Clinics of North America, Vol. 88, No. 6, 11.2004, p. 1593-1605.

Research output: Contribution to journalArticle

Ebbert, Jon Owen ; Carr, Alan B. ; Dale, Lowell C. / Smokeless tobacco : An emerging addiction. In: Medical Clinics of North America. 2004 ; Vol. 88, No. 6. pp. 1593-1605.
@article{44c9a31ec5c14578b136eb801ab8e2a2,
title = "Smokeless tobacco: An emerging addiction",
abstract = "Smokeless tobacco use is prevalent in the United States and long-term use leads to significant morbidity. ST users are exposed to high levels of nicotine and are observed to graduate to higher nicotine-containing ST products, perpetuating nicotine dependence. Although few proved pharmacotherapies exist, available evidence suggests that bupropion SR might be effective for increasing ST abstinence rates. Behavioral therapies that include an oral examination may be especially effective for this population of tobacco users. Nicotine replacement therapy should be used to treat withdrawal symptoms in ST users attempting to stop.",
author = "Ebbert, {Jon Owen} and Carr, {Alan B.} and Dale, {Lowell C.}",
year = "2004",
month = "11",
doi = "10.1016/j.mcna.2004.06.003",
language = "English (US)",
volume = "88",
pages = "1593--1605",
journal = "Medical Clinics of North America",
issn = "0025-7125",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Smokeless tobacco

T2 - An emerging addiction

AU - Ebbert, Jon Owen

AU - Carr, Alan B.

AU - Dale, Lowell C.

PY - 2004/11

Y1 - 2004/11

N2 - Smokeless tobacco use is prevalent in the United States and long-term use leads to significant morbidity. ST users are exposed to high levels of nicotine and are observed to graduate to higher nicotine-containing ST products, perpetuating nicotine dependence. Although few proved pharmacotherapies exist, available evidence suggests that bupropion SR might be effective for increasing ST abstinence rates. Behavioral therapies that include an oral examination may be especially effective for this population of tobacco users. Nicotine replacement therapy should be used to treat withdrawal symptoms in ST users attempting to stop.

AB - Smokeless tobacco use is prevalent in the United States and long-term use leads to significant morbidity. ST users are exposed to high levels of nicotine and are observed to graduate to higher nicotine-containing ST products, perpetuating nicotine dependence. Although few proved pharmacotherapies exist, available evidence suggests that bupropion SR might be effective for increasing ST abstinence rates. Behavioral therapies that include an oral examination may be especially effective for this population of tobacco users. Nicotine replacement therapy should be used to treat withdrawal symptoms in ST users attempting to stop.

UR - http://www.scopus.com/inward/record.url?scp=4644242040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644242040&partnerID=8YFLogxK

U2 - 10.1016/j.mcna.2004.06.003

DO - 10.1016/j.mcna.2004.06.003

M3 - Article

C2 - 15464115

AN - SCOPUS:4644242040

VL - 88

SP - 1593

EP - 1605

JO - Medical Clinics of North America

JF - Medical Clinics of North America

SN - 0025-7125

IS - 6

ER -